Lisanti Capital Growth’s Chemed CHE Stock Holding History

Lisanti Capital Growth’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-1,230	Closed	-$396K	–	124
2018 Q2	$396K	Buy	+1,230	New	+$385K	0.15%	129

Other funds holding CHE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return

Lisanti Capital Growth's CHE Position: Q3 2018 in Review

Lisanti Capital Growth sold out of Chemed (CHE) in Q3 2018, closing a stake of 1,230 shares — an estimated $396K sold.

Lisanti Capital Growth first reported a position in CHE in Q2 2018 and held it in 1 quarter. The position peaked at $396K in Q2 2018. 352 funds tracked by Wall St. Rank hold CHE as of Q3 2018.

Lisanti Capital Growth reported no remaining Chemed position as of Q3 2018 after selling out during the quarter.
Lisanti Capital Growth sold 1,230 Chemed shares in Q3 2018, an estimated $396K.
Lisanti Capital Growth first reported a position in Chemed in Q2 2018 and held it in 1 quarter.
Lisanti Capital Growth's Chemed position peaked at $396K in Q2 2018.
352 funds tracked by Wall St. Rank held Chemed as of Q3 2018.

Based on Lisanti Capital Growth's 13F filing for Q3 2018, filed 5 Nov 2018.